News
It has been roughly nine months since my previous Moderna (NASDAQ:MRNA) article, when I discussed GlaxoSmithKline’s (GSK) lawsuit against the company over their lipid nanoparticle technology, and it ...
StockStory.org on MSN16h
Why Moderna (MRNA) Stock Is Falling TodayWhat Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added ...
The FDA action comes weeks after US Health Secretary Robert F. Kennedy Jr said the government would no longer recommend the COVID vaccine for healthy children or pregnant people.
3d
Zacks.com on MSNMRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric PatientsModerna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results